Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2015-02-06 10:00:16
Reporting Period:
Filing Date:
Accepted Time:
2015-02-06 10:00:16
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1359067 W Derica Rice Lilly Corporate Center
Indianapolis IN 46285
Evp-Global Services And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-04 5,316 $70.00 55,061 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,958 Indirect 401(k)
Common Stock 278,263 Indirect by wife
Common Stock 1,809 Indirect 401(k) - by wife
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2014.
  2. This transaction was executed in multiple trades at prices ranging from $69.85 to $70.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Reporting person disclaims beneficial ownership of these shares.